Effect of Physical Exercise on Bone Density and Remodeling in Egyptian Type 1 Diabetic Osteopenic Adolescents

<p>Abstract</p> <p>Background</p> <p>The study was planned to assess effect of physical exercise on bone remodeling in type I diabetics with osteopenia.</p> <p>Methods</p> <p>Twenty-four type I diabetes mellitus (DM1) with osteopenia (10 females and 14 males) were compared to thirty-eight age- and sex-matched healthy control individuals (20 females and 18 males) for biochemical and radiologic parameters of bone mass. Laboratory investigations included serum and urinary calcium, inorganic phosphorus, alkaline phosphatase, and serum "procollagen type 1 N-terminal propeptide (P1NP). Bone densitometry was assessed at neck femur using Dual Energy X-ray Absorptiometry (DEXA). Serum P1NP and DEXA were reevaluated after a planned exercise program.</p> <p>Results</p> <p>Patients and controls were comparable with respect to serum as well as urinary biochemical parameters of bone mass namely; calcium, phosphorus and total serum alkaline phosphatase. Osteopenic DM1 patients displayed lower mean serum P1NP than control group (20.11 ± 6.72 ugdL versus 64.96 ± 34.89 ugdL; p < 0.05). A significant correlation was observed between BMD and degree of glycemic control reflected by serum glycated hemoglobin (r = -0.44, p, 0.030). Bone densitometry correlated with serum P1NP (r = -0.508, p, 0.011). After a planned regular exercise for 3 months, serum P1NP and BMD levels increased with percentage change of 40.88 ± 31.73 and 3.36 ± 2.94, respectively. Five patients resumed normal densitometry and they were all males.</p> <p>Conclusion</p> <p>Diabetic osteopenic patients displayed lower serum levels of procollagen type 1 N-terminal propeptide which reflects poor bone formation. A 3-months planned exercise program was associated with improvement of bone densitometry and significant increment of serum P1NP.</p

Simultaneous pulmonary administration of celecoxib and naringin using a nebulization-friendly nanoemulsion:A device-targeted delivery for treatment of lung cancer

Lung cancer is a principal cause of death worldwide, and its treatment is very challenging. Nebulization offers a promising means of targeting drugs to their site of action in the lung. In the present study, nebulizable oil in water nanoemulsion formulations was co-loaded with naringin/celecoxib and tested for pulmonary administration by different nebulizer types. The translucent appearance of nanoemulsion formulations was revealed, with particle size (75-106 nm), zeta potential (-3.42 to -4.86 mV), and controlled release profiles for both drugs. The nanoemulsions showed favorable stability profiles and superior cytotoxicity on A549 lung cancer cells. Aerosolization studies on the selected nanoemulsion formulation revealed its high stability during nebulization, with the generation of an aerosol of small volume median diameter and mass median aerodynamic diameter lower than 5 µm. Moreover, it demonstrated considerable safety and bioaccumulation in lung tissues, in addition to accumulation in the brain, liver, and bones, which are the main organs to which lung cancer metastasizes. Nanoemulsion proved to be a promising nebulizable system, which paves the way for treatment of pulmonary diseases other than lung cancer

Antimicrobial Efficacy and HPLC Analysis of Polyphenolic Compounds in a Whole-Plant Extract of <i>Eryngium campestre</i>

Due to the constant increase in the number of plant diseases and the lack of available treatments, there has been a growing interest in plant extracts over the past few decades. Numerous studies suggest that plant extract molecules possess valuable antimicrobial activities, particularly against fungi and bacteria. This suggests that these biomaterials could potentially serve as attractive therapeutic options for the treatment of phytopathogen infections. In the present study, we investigated and analyzed the methanolic extract of Eryngium campestre L. whole plant extract using HPLC. The analysis revealed the presence of several polyphenolic constituents, with benzoic acid, catechol, quercetin, vanillic acid, resveratrol, naringenin, and quinol being the most abundant. The amounts of these constituents were determined to be 2135.53, 626.728, 579.048, 356.489, 323.41, 153.038, and 128.77 mg/kg, respectively. Furthermore, we isolated and identified different plant fungal and bacterial isolates from symptomatic potato plants, which were accessioned as Rhizoctonia solani (OQ880458), Fusarium oxysporum (OQ820156) and Fusarium solani (OQ891085), Ralstonia solanacearum (OQ878653), Dickeya solani (OQ878655), and Pectobacterium carotovorum (OQ878656). The antifungal activity of the extract was assessed using fungal growth inhibitions (FGI) at concentrations of 100, 200, and 300 µg/mL. The results showed that at the lowest concentration tested (100 µg/mL), the extract exhibited the highest effectiveness against R. solani with an FGI of 78.52%, while it was least effective against F. solani with an FGI of 61.85%. At the highest concentration tested, the extract demonstrated the highest effectiveness against R. solani and F. oxysporum, with FGIs of 88.89% and 77.04%, respectively. Additionally, the extract displayed a concentration-dependent inhibitory effect on all three bacterial pathogens. At the highest concentration tested (3000 µg/mL), the extract was able to inhibit the growth of all three bacterial pathogens, although the inhibition zone diameter varied. Among the bacterial pathogens, D. solani exhibited the highest sensitivity to the extract, as it showed the largest inhibition zone diameter at most of the extract concentrations. These findings highlight the potential of the E. campestre extract as a source of natural antimicrobial agents for controlling various plant pathogens. Consequently, it offers a safer alternative to the currently employed protective methods for plant disease management

Toward an automated dental identification system

This paper addresses the problem of developing an automated system for postmortem identification using dental records. The Automated Dental Identification System (ADIS) can be used by law enforcement agencies to locate missing persons using databases of dental x-rays. Currently, this search and identification process is carried out manually, which makes it very timeconsuming and unreliable. In this paper, we propose an architecture for ADIS, we define the functionality of its components, and we briefly describe some of the techniques used in realizing these components

Towards an Automated Dental Identification System (ADIS)

This paper addresses the problem of developing an automated system for postmortem identification using dental records. The Automated Dental Identification System (ADIS) can be used by law enforcement agencies to locate missing persons using databases of dental x-rays. Currently, this search and identification process is carried out manually, which makes it very time-consuming and unreliable. In this paper, we propose architecture for ADIS, we define the functionality of its components, and we briefly describe some of the techniques used in realizing these components